Thirty nine phenotypes of human leucocyte antigens (HLA)-A-B-DR and DQ were obtained from 99 asbestos workers (one woman and 98 men). Presence or absence of antinuclear antibodies and rheumatoid factor was determined in 91 of them. Workers were divided into five groups: asbestos workers with no apparent disease (AW; n = 17), diffuse benign pleural disease (PD; n = 31), asbestosis (AS; n = 24), asbestosis with lung cancer (AS-CA; n = 14), and mesothelioma (M; n = 13). Compared with AW, several trends of differences of HLA antigen prevalence were found in patients with asbestos related disease, but these did not achieve statistical significance when p was corrected (Pcorr) by number of analyses undertaken. Analysis of the results obtained in previous studies together with the results of this study showed that compared with AW, AS patients had decreased prevalence of HLA-DR5 (PcOrr < 002). Reasons for the differences in results ofprevious studies and statistical methods commonly used to compare prevalences of HLA antigen are discussed.
circulating immunoglobulins," autoantibodies,'0 and the complement components. 5 Other studies have shown alterations of the lymphocyte subsets in the peripheral blood of asbestos workers with and without asbestosis.
The fibrotic response to asbestos fibres could be genetically controlled; there is evidence from animal models that susceptibility to interstitial lung disease may be modified by immune and non-immune related genes.'2 The human leucocyte antigen (HLA) has been linked with the immune response capability and close associations between some types of HLA and immunological conditions such as ankylosing spondylitis have been established.'3 Several studies investigating associations between types of the HLA system and the occurrence of asbestosis have been published with inconsistent and sometimes conflicting results.'"2' All but one of these studies2' investigated the loci of the class I HLA (HLA-A-B-C) but not class II (HLA-DR, DQ, and DW). Recently a predisposition to development of idiopathic pulmonary fibrosis has been associated with one of the B cell autoantigens, HLA-DR2. 22 In this study we investigated class I and class II HLA in patients with different types of asbestos related disease and compared prevalences of HLAs between different groups using the data obtained in this and previously published studies.
Patients and methods

PATIENTS
We studied 98 white men and one white woman. Their mean age (range) was 59 (35-79). They were divided into five groups: asbestosis (AS; n = 24), benign pleural disease (PD; n = 31), asbestosis and lung cancer (AS-CA; n = 14), mesothelioma (M; n = 13), and heavy asbestos exposure (two years or more) with no apparent disease (AW; n = 17).
The diagnosis of asbestosis was made on the basis of a history of exposure to asbestos and shadowing on chest radiographs or high resolution computed tomography (HRCT) scans consistent with interstitial fibrosis. Asbestos bodies were detected in bronchoalveolar lavage fluid in the 11 patients in whom this was carried out.
Pleural disease and opacities suggestive of asbes-tosis were present on chest radiographs in all patients with lung cancer and asbestosis was confirmed by HRCT in four patients on whom this was performed. Pathological evidence of asbestosis was obtained from the two patients who underwent lobectomy. Histological confirmation oflung cancer was available for all patients with this disease and the cell types were small cell carcinoma (9), squamous cell carcinoma (4), and adenocarcinoma (one patient). The diagnosis of mesothelioma was made on the basis of progressive chest pain, weight loss, and irregular pleural thickening with reduction of thoracic volume on chest radiographs. A histological diagnosis was obtained during life in 12 patients and at postmortem examination in one patient. Immunohistochemical stains were used as well as routine histological methods.
Patients classified as having benign pleural disease had plain chest radiographic evidence of pleural plaques or pleural thickening of at least lb grade on the International Labour Office (ILO) scale (length ofpleural disease ofmore than a quarter of the lateral chest wall and maximum width more than 0-5 cm)23 with or without involvement of the costophrenic angles. The diagnosis of interstitial fibrosis was ruled out on the basis of HRCT in all patients.
Those patients with past occupational exposure to asbestos and in whom the chest radiographs had shown no evidence of pleural disease and pulmonary opacities of less than 1/0 were classified as AW. A diagnosis of asbestosis was ruled out on the basis of HRCT in all patients.
Exposure to asbestos was through lagging in 35, stripping asbestos in 16, loading and unloading asbestos in the shipyards (the docks) in 21, building trade in 17, and driving lorries occasionally loaded with asbestos in six patients. Non-occupational (domestic) asbestos exposure had occurred in four patients.
Thirty five patients were current smokers (smoked during the past three months), 52 were ex-smokers (smoked more than 20 lifetime packs and no cigarettes during the last three months), and 12 were nonsmokers (smoked less than 20 lifetime packs and no cigarettes during the last three months).
None of the patients had any clinical evidence of connective tissue disease, had received corticosteroids for at least three months, or had clinical symptoms of any viral disease during six weeks before the blood samples were taken. In patients with lung cancer, blood was withdrawn before any chemotherapy.
METHODS
Blood withdrawal Blood (50 ml) was withdrawn using a butterfly needle (gauge 19) and was divided into four tubes: 18 ml of blood in 2 ml of 3-8% citrate for HLA typing, 20 ml with 200 units of preservative free heparin for lymphocyte separation, 2 ml with ethylene diaminetetra-acetic acid for full blood cell count and differential white blood cell count, and 10 ml untreated for detecting rheumatoid factor and antinuclear antibodies.
HLA typing Thirty nine phenotypes of HLA-A-B, DR, and DQ were obtained from the fresh blood using a standard National Institute of Health 2-stage complement dependent microlymphocytotoxicity assay defining eight HLA-A and 17 HLA-B types according to methods described by Amos and Pool, 24 5  14  0  6  2  11  11  2  8  7  21  5  7  6  22  17  12  24  8  19  2  10  10  20  31  4  1 1  12  19  5  10  18  20  26  3  12  13  6  3  2  2  3  6  1  3  14  6  0  3  4  8  8  0  0  15  6  1  0  1  10  1 1  6  16  16  11  2  1  0  5  4  4  5  17  11  2  3  5  7  9  0  0  18  5  1  3  8  7  9  7  3  21  5  0  2  2  3  7  0  0  22  4  0  3  1  4  4  0  0  27  11  6  3  2  4  11  11  9  35  16  5   --1 1  7  10  16  37  13  3  --2  3  0  1  40*  ----12  9  9  11  W4  ------17  28  W6  ------36 Presence of absence of antinuclear antibodies and rheumatoid factor was determined in 91 patients.
Results
There was no difference in the prevalence ofany HLA between patients in whom antinuclear antibodies were (n = 19) or were not (n = 72) detected. Similarly there were no differences in prevalence of any HLA in those patients in whom rheumatoid factor was present (n = 6) or absent (n = 85).
A review of publications showed that HLA A and B antigens have been investigated in a total of 355 asbestos workers with no disease (AW) and 289 patients with asbestosis (AS) in studies by Matej et The total numbers of patients differ from n = 355 and n = 289 in some instances. These are shown by superscripts. The numbers are a297, a'232, b216, b'230, c328, c'252, d270, d'195, e54, e'72. In the current study p was corrected according to the method of Sidak" and Dunn32; and Pcorr < 0-05 was accepted as the significance level.
Pack-years of cigarette smoking in AS and AS-CA patients were higher than in PD and AW patients, whereas the duration of exposure to asbestos and time since first exposure did not differ between types of asbestos related disease. These results are consistent with several studies that have found an increase in radiographic opacities suggestive of asbestosis in asbestos workers who smoked compared with those who did not."" '8 In conclusion, our data show no significant associations between types of HLA and types of asbestos related disease by data from this study and a previously reported study combined suggest a possible protective effect of HLA-DR5 against asbestosis.
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